The osteogenic markers were improved after being treated with 4-phenyl butyric acid (4-PBA, an ER stress inhibitor) [37]; the functionality of osteoblast was diminished, resulting in the development of osteopenia in DDIT3 transgenic mice [8]. This evidence concerns the gene DDIT3 and Osteopenia.